Development and characterization of clinically relevant tumor models from patients with renal cell carcinoma.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  European Urology

• Publication date

  2011-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.eururo.2010.11.043PMID 21167632
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Establishment and Characterization of a Panel of Human Uveal Melanoma Xenografts Derived from Primary and/or Metastatic Tumors

  2010cited by this paper
• Sunitinib acts primarily on tumor endothelium rather than tumor cells to inhibit the growth of renal cell carcinoma.

  2010cited by this paper
• Clinical relevance of human cancer xenografts as a tool for preclinical assessment: example of in-vivo evaluation of topotecan-based chemotherapy in a panel of human small-cell lung cancer xenografts

  2010cited by this paper
• Interleukin-8 mediates resistance to antiangiogenic agent sunitinib in renal cell carcinoma.

  2010cited by this paper
• Small interference RNA targeting Krüppel-like factor 8 inhibits the renal carcinoma 786-0 cells growth in vitro and in vivo

  2010cited by this paper
• Disruption of angiogenesis and tumor growth with an orally active drug that stabilizes the inactive state of PDGFRβ/B-RAF

  2010cited by this paper
• Aberrant epithelial morphology and persistent epidermal growth factor receptor signaling in a mouse model of renal carcinoma

  2009cited by this paper
• Antitumor and antiangiogenic activity of cediranib in a preclinical model of renal cell carcinoma.

  2009cited by this paper
• Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial

  2009cited by this paper
• Cancer Statistics, 2009

  2009cited by this paper
• Familial renal adenomas in Wistar rats; a preliminary report.

  2009cited by this paper
• Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial.

  2008cited by this paper
• Type III Transforming Growth Factor-β (TGF-β) Receptor Mediates Apoptosis in Renal Cell Carcinoma Independent of the Canonical TGF-β Signaling Pathway

  2008cited by this paper
• Cell Line Data Base: structure and recent improvements towards molecular authentication of human cell lines

  2008cited by this paper
• Sunitinib versus interferon alfa in metastatic renal-cell carcinoma.

  2007cited by this paper
• Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial.

  2007cited by this paper
• A New Model of Patient Tumor-Derived Breast Cancer Xenografts for Preclinical Assays

  2007cited by this paper
• Sorafenib in advanced clear-cell renal-cell carcinoma.

  2007cited by this paper
• Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma.

  2007cited by this paper
• Progression of renal cell carcinoma is inhibited by genistein and radiation in an orthotopic model

  2007cited by this paper
• An In vivo Platform for Translational Drug Development in Pancreatic Cancer

  2006cited by this paper
• MALDI‐TOF MS and TaqMan® assisted SNP genotyping of DNA isolated from formalin‐fixed and paraffin‐embedded tissues (FFPET)

  2005cited by this paper
• Typing of XY (male) genotype from malignant neoplastic tissue by the amelogenin-based sex test.

  2004cited by this paper
• Debulking Nephrectomy in Metastatic Renal Cancer

  2004cited by this paper
• MS analysis of single-nucleotide differences in circulating nucleic acids: Application to noninvasive prenatal diagnosis.

  2004cited by this paper
• Clonogenic assay with established human tumour xenografts: correlation of in vitro to in vivo activity as a basis for anticancer drug discovery.

  2004cited by this paper
• Conditional Suppression of Cellular Genes: Lentivirus Vector-Mediated Drug-Inducible RNA Interference

  2003cited by this paper
• The changing natural history of renal cell carcinoma.

  2001cited by this paper
• High-throughput development and characterization of a genomewide collection of gene-based single nucleotide polymorphism markers by chip-based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

  2001cited by this paper
• Caspase-dependent apoptosis induced by telomere cleavage and TRF2 loss.

  2000cited by this paper
• Reliability of DNA-based sex tests

  1998cited by this paper
• Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo

  1997cited by this paper
• A germline insertion in the tuberous sclerosis (Tsc2) gene gives rise to the Eker rat model of dominantly inherited cancer

  1995cited by this paper
• Nude mouse metastatic models of human stomach cancer constructed using orthotopic implantation of histologically intact tissue.

  1993cited by this paper
• A metastatic nude-mouse model of human pancreatic cancer constructed orthotopically with histologically intact patient specimens.

  1992cited by this paper
• Human RT‐4 bladder carcinoma is highly metastatic in nude mice and comparable ras‐H‐transformed RT‐4 when orthotopically onplanted as histologically intact tisuee

  1992cited by this paper
• Human ovarian cancer xenografts in nude mice: Characterization and analysis of antigen expression

  1991cited by this paper
• Extensive multi‐organ metastasis following orthotopic onplantation of histologically‐intact human bladder carcinoma tissue in nude mice

  1991cited by this paper
• Stability of human renal cell carcinomas during long term serial transplantation into nude mice: histopathology, nuclear grade, mitotic rate, and DNA content in thirty tumors.

  1987cited by this paper
• Long-term serial transplantation of 30 different human renal cell carcinomas into NMRI (nu/nu) mice: flow cytometric, histologic, and growth studies.

  1986cited by this paper
• Transplantation of human renal carcinomas into athymic mice.

  1985cited by this paper
• Transplantation of human renal cell carcinoma into NMRI nu/nu mice. I. Reliability of an experimental tumor model.

  1984cited by this paper
• The response to chemotherapy of a variety of human tumour xenografts.

  1983cited by this paper
• Renal cell carcinoma: two new cell lines and a serially transplantable nude mouse tumor (NC 65). Preliminary report.

  1978cited by this paper
• Maintenance of biological and biochemical characteristics of human colorectal tumours during serial passage in immune-deprived mice.

  1978cited by this paper
• A murine renal cell carcinoma.

  1973cited by this paper

• Differential Efficacy of Bevacizumab and Erlotinib in Preclinical Models of Renal Medullary Carcinoma and Fumarate Hydratase-Deficient Renal Cell Carcinoma.

  2025cites this paper
• Bioprinted research models of urological malignancy

  2024cites this paper
• PKM2 allosteric converter: A self-assembly peptide for suppressing renal cell carcinoma and sensitizing chemotherapy.

  2023cites this paper
• Lipid Metabolism Pathway and Renal Tumor Therapy

  2023cites this paper
• Combining MTI-31 with RAD001 inhibits tumor growth and invasion of kidney cancer by activating autophagy

  2023cites this paper
• A reactive oxygen species–related signature to predict prognosis and aid immunotherapy in clear cell renal cell carcinoma

  2023cites this paper
• Neddylation inhibition sensitises renal medullary carcinoma tumours to platinum chemotherapy

  2023cites this paper
• Preclinical models for development of immune-oncology therapies.

  2022cites this paper
• Identification of a Necroptosis-Related Prognostic Index and Associated Regulatory Axis in Kidney Renal Clear Cell Carcinoma

  2022cites this paper
• ACSL3 regulates lipid droplet biogenesis and ferroptosis sensitivity in clear cell renal cell carcinoma

  2022cites this paper
• The SUMO protease SENP1 promotes aggressive behaviors of high HIF2α expressing renal cell carcinoma cells

  2022cites this paper
• A renal cell carcinoma tumorgraft platform to advance precision medicine

  2021cites this paper
• Patient-Derived Xenograft Models in Urological Malignancies: Urothelial Cell Carcinoma and Renal Cell Carcinoma

  2020cites this paper
• Patient-derived models of brain metastases recapitulate the histopathology and biology of human metastatic cancers

  2020cites this paper
• Kidney cancer PDOXs reveal patient‐specific pro‐malignant effects of antiangiogenics and its molecular traits

  2020cites this paper
• Comprehensive Molecular Characterization Identifies Distinct Genomic and Immune Hallmarks of Renal Medullary Carcinoma.

  2020cites this paper
• Choosing The Right Animal Model for Renal Cancer Research☆

  2020cites this paper
• S100A10 is a critical mediator of GAS6/AXL-induced angiogenesis in renal cell carcinoma.

  2019cites this paper
• Patient-derived xenograft models to optimize kidney cancer therapies.

  2019cites this paper
• Modulating ATP binding cassette transporters in papillary renal cell carcinoma type 2 enhances its response to targeted molecular therapy

  2018influential citation
• Renal cancer: new models and approach for personalizing therapy

  2018cites this paper
• Attenuation of everolimus-induced cytotoxicity by a protective autophagic pathway involving ERK activation in renal cell carcinoma cells

  2018cites this paper
• Intermittent hypoxia increases kidney tumor vascularization in a murine model of sleep apnea

  2017cites this paper
• Experimental imaging in orthotopic renal cell carcinoma xenograft models: comparative evaluation of high-resolution 3D ultrasonography, in-vivo micro-CT and 9.4T MRI

  2017cites this paper
• Patient-derived xenografts as in vivo models for research in urological malignancies

  2017cites this paper
• Insights from animal models of bladder cancer: recent advances, challenges, and opportunities

  2017cites this paper
• Humanized Mouse and Rat PDX Cancer Models

  2017cites this paper
• Acides aminés et cancer : LAT1, un transporteur essentiel à l’activité mTORC1 et la croissance tumorale

  2016cites this paper
• Establishment of a large panel of patient-derived preclinical models of human renal cell carcinoma

  2016cites this paper
• Tumor Xenografts of Human Clear Cell Renal Cell Carcinoma But Not Corresponding Cell Lines Recapitulate Clinical Response to Sunitinib: Feasibility of Using Biopsy Samples.

  2016cites this paper
• The Challenges of Modeling Drug Resistance to Antiangiogenic Therapy.

  2016cites this paper
• How anti-angiogenic drugs are able to induce resistance to their own therapeutic effect in human metastatic renal carcinoma

  2015cites this paper
• Human anti-CAIX antibodies mediate immune cell inhibition of renal cell carcinoma in vitro and in a humanized mouse model in vivo

  2015cites this paper
• Tracking sub-clonal TP53 mutated tumor cells in human metastatic renal cell carcinoma

  2015cites this paper
• Ovarian carcinoma patient derived xenografts reproduce their tumor of origin and preserve an oligoclonal structure

  2015cites this paper
• The future of patient-derived tumor xenografts in cancer treatment.

  2015cites this paper
• For the RECORD, we should SWITCH our treatment AXIS before the SUNRISES and TARGET the BEST treatments before INTORSECTing with a GOLD METEOR: a tale of sequences and combinations.

  2015cites this paper
• Carcinomes rénaux : caractérisation moléculaire et des voies métaboliques dépendant des mécanismes hypoxiques

  2015cites this paper
• Resistance to sunitinib in renal clear cell carcinoma results from sequestration in lysosomes and inhibition of the autophagic flux

  2015cites this paper
• The Relevance of Testing the Efficacy of Anti-Angiogenesis Treatments on Cells Derived from Primary Tumors: A New Method for the Personalized Treatment of Renal Cell Carcinoma

  2014cites this paper
• Establishing a human renal cell carcinoma tumorgraft platform for preclinical drug testing

  2014cites this paper
• Translational Validation of Personalized Treatment Strategy Based on Genetic Characteristics of Glioblastoma

  2014cites this paper
• One mouse, one patient paradigm: New avatars of personalized cancer therapy.

  2014cites this paper
• Colorectal cancer patient-derived xenografted tumors maintain characteristic features of the original tumors.

  2014cites this paper
• The role of inflammation in kidney cancer.

  2014cites this paper
• Resistance to tyrosine kinase inhibitors in clear cell renal cell carcinoma: from the patient's bed to molecular mechanisms.

  2014cites this paper
• Tissue slice grafts of human renal cell carcinoma: an authentic preclinical model with high engraftment rate and metastatic potential.

  2014influential citation
• Stability of preclinical models of aggressive renal cell carcinomas.

  2014cites this paper
• Patient-specific orthotopic glioblastoma xenograft models recapitulate the histopathology and biology of human glioblastomas in situ.

  2013cites this paper
• Cancer Therapy : Preclinical Autotaxin – Lysophosphatidic Acid Signaling Axis Mediates Tumorigenesis and Development of Acquired Resistance to Sunitinib in Renal Cell Carcinoma

  2013cites this paper
• Angiogenic and signalling proteins correlate with sensitivity to sequential treatment in renal cell cancer

  2013influential citation
• Oncolytic Reovirus Combined with Sunitinib as a Novel Multi-Mechanistic Treatment Strategy for Renal Cell Carcinoma

  2013cites this paper
• Renal cell carcinoma: translational aspects of metabolism and therapeutic consequences.

  2013cites this paper
• Development and characterization of a bladder cancer xenograft model using patient‐derived tumor tissue

  2013cites this paper
• Cox-2 inhibition enhances the activity of sunitinib in human renal cell carcinoma xenografts

  2013cites this paper
• Toll-like receptor 9 agonist IMO cooperates with everolimus in renal cell carcinoma by interfering with tumour growth and angiogenesis

  2013cites this paper
• Autotaxin–Lysophosphatidic Acid Signaling Axis Mediates Tumorigenesis and Development of Acquired Resistance to Sunitinib in Renal Cell Carcinoma

  2013cites this paper
• Genomic Heterogeneity of Translocation Renal Cell Carcinoma

  2013cites this paper
• A Validated Tumorgraft Model Reveals Activity of Dovitinib Against Renal Cell Carcinoma

  2012cites this paper
• Von Hippel-Lindau disease (VHL): a need for a murine model with retinal hemangioblastoma.

  2012cites this paper
• Orthotopic xenografts of RCC retain histological, immunophenotypic and genetic features of tumours in patients

  2011cites this paper